268 related articles for article (PubMed ID: 26063678)
1. Dissociable effects of mGluR5 allosteric modulation on distinct forms of impulsivity in rats: interaction with NMDA receptor antagonism.
Isherwood SN; Pekcec A; Nicholson JR; Robbins TW; Dalley JW
Psychopharmacology (Berl); 2015 Sep; 232(18):3327-44. PubMed ID: 26063678
[TBL] [Abstract][Full Text] [Related]
2. Bidirectional variation in glutamate efflux in the medial prefrontal cortex induced by selective positive and negative allosteric mGluR5 modulators.
Isherwood SN; Robbins TW; Dalley JW; Pekcec A
J Neurochem; 2018 Apr; 145(2):111-124. PubMed ID: 29315577
[TBL] [Abstract][Full Text] [Related]
3. Enhanced attention and impulsive action following NMDA receptor GluN2B-selective antagonist pretreatment.
Higgins GA; Silenieks LB; MacMillan C; Sevo J; Zeeb FD; Thevarkunnel S
Behav Brain Res; 2016 Sep; 311():1-14. PubMed ID: 27180168
[TBL] [Abstract][Full Text] [Related]
4. mGluR5 antagonist-induced psychoactive properties: MTEP drug discrimination, a pharmacologically selective non-NMDA effect with apparent lack of reinforcing properties.
Swedberg MD; Ellgren M; Raboisson P
J Pharmacol Exp Ther; 2014 Apr; 349(1):155-64. PubMed ID: 24472725
[TBL] [Abstract][Full Text] [Related]
5. A novel mGluR5 antagonist, MFZ 10-7, inhibits cocaine-taking and cocaine-seeking behavior in rats.
Keck TM; Zou MF; Bi GH; Zhang HY; Wang XF; Yang HJ; Srivastava R; Gardner EL; Xi ZX; Newman AH
Addict Biol; 2014 Mar; 19(2):195-209. PubMed ID: 24001208
[TBL] [Abstract][Full Text] [Related]
6. Selective and interactive effects of D
Isherwood SN; Robbins TW; Nicholson JR; Dalley JW; Pekcec A
Neuropharmacology; 2017 Sep; 123():249-260. PubMed ID: 28487067
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of social novelty discrimination by positive allosteric modulators at metabotropic glutamate 5 receptors: adolescent administration prevents adult-onset deficits induced by neonatal treatment with phencyclidine.
Clifton NE; Morisot N; Girardon S; Millan MJ; Loiseau F
Psychopharmacology (Berl); 2013 Feb; 225(3):579-94. PubMed ID: 22983144
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.
Lea PM; Movsesyan VA; Faden AI
Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750
[TBL] [Abstract][Full Text] [Related]
9. Effects of the NMDA receptor antagonists dizocilpine and Ro 63-1908 on delay-discounting and risky decision-making in a gambling task.
Higgins GA; Silenieks LB; MacMillan C; Zeeb FD; Thevarkunnel S
Behav Brain Res; 2018 Aug; 348():201-210. PubMed ID: 29689373
[TBL] [Abstract][Full Text] [Related]
10. Negative versus positive allosteric modulation of metabotropic glutamate receptors (mGluR5): indices for potential pro-cognitive drug properties based on EEG network oscillations and sleep-wake organization in rats.
Ahnaou A; Langlois X; Steckler T; Bartolome-Nebreda JM; Drinkenburg WH
Psychopharmacology (Berl); 2015 Mar; 232(6):1107-22. PubMed ID: 25323624
[TBL] [Abstract][Full Text] [Related]
11. Effects of N-methyl-D-aspartate receptor ligands on sensitivity to reinforcer magnitude and delayed reinforcement in a delay-discounting procedure.
Yates JR; Gunkel BT; Rogers KK; Hughes MN; Prior NA
Psychopharmacology (Berl); 2017 Feb; 234(3):461-473. PubMed ID: 27837332
[TBL] [Abstract][Full Text] [Related]
12. Effects of the selective 5-HT7 receptor antagonist SB-269970 on premature responding in the five-choice serial reaction time test in rats.
Nikiforuk A; Hołuj M; Potasiewicz A; Popik P
Behav Brain Res; 2015 Aug; 289():149-56. PubMed ID: 25930219
[TBL] [Abstract][Full Text] [Related]
13. The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles.
Varty GB; Grilli M; Forlani A; Fredduzzi S; Grzelak ME; Guthrie DH; Hodgson RA; Lu SX; Nicolussi E; Pond AJ; Parker EM; Hunter JC; Higgins GA; Reggiani A; Bertorelli R
Psychopharmacology (Berl); 2005 Apr; 179(1):207-17. PubMed ID: 15682298
[TBL] [Abstract][Full Text] [Related]
14. Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats.
Carli M; Baviera M; Invernizzi RW; Balducci C
Neuropsychopharmacology; 2006 Apr; 31(4):757-67. PubMed ID: 16192987
[TBL] [Abstract][Full Text] [Related]
15. mGluR5, but not mGluR1, antagonist modifies MK-801-induced locomotor activity and deficit of prepulse inhibition.
Pietraszek M; Gravius A; Schäfer D; Weil T; Trifanova D; Danysz W
Neuropharmacology; 2005 Jul; 49(1):73-85. PubMed ID: 15992582
[TBL] [Abstract][Full Text] [Related]
16. Differences in trait impulsivity do not bias the response to pharmacological drug challenge in the rat five-choice serial reaction time task.
Barlow RL; Dalley JW; Pekcec A
Psychopharmacology (Berl); 2018 Apr; 235(4):1199-1209. PubMed ID: 29374304
[TBL] [Abstract][Full Text] [Related]
17. The 5-HT2A receptor antagonist M100,907 attenuates motor and 'impulsive-type' behaviours produced by NMDA receptor antagonism.
Higgins GA; Enderlin M; Haman M; Fletcher PJ
Psychopharmacology (Berl); 2003 Nov; 170(3):309-319. PubMed ID: 12904968
[TBL] [Abstract][Full Text] [Related]
18. Group I metabotropic glutamate receptor antagonists impair discriminability of reinforcer magnitude, but not risky choice, in a probability-discounting task.
Yates JR; Chitwood MR; Evans KE; Kappesser JL; Murray CP; Paradella-Bradley TA; Torline BT
Behav Brain Res; 2019 Jun; 365():77-81. PubMed ID: 30831139
[TBL] [Abstract][Full Text] [Related]
19. AZD9272 and AZD2066: selective and highly central nervous system penetrant mGluR5 antagonists characterized by their discriminative effects.
Swedberg MD; Raboisson P
J Pharmacol Exp Ther; 2014 Aug; 350(2):212-22. PubMed ID: 24876235
[TBL] [Abstract][Full Text] [Related]
20. Neurophysiological signals as potential translatable biomarkers for modulation of metabotropic glutamate 5 receptors.
Harvey BD; Siok CJ; Kiss T; Volfson D; Grimwood S; Shaffer CL; Hajós M
Neuropharmacology; 2013 Dec; 75():19-30. PubMed ID: 23831682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
